DifficultiesinDiagnosingPeritonealMesothelioma (RareClinicalCase)
The goal of the study was to draw the attention of surgeons, angiosurgeons, infectious disease specialists and oncologists to non-standard predictors of peritoneal mesothelioma development and peculiarities of its diagnostics. The artice presents the analysis of publications on the diagnosis of malignant peritoneal mesothelioma and our own clinical observation with unusual disease debut: cervical lymphadenopathy, thrombosis of the branches of the superior vena cava, bilateral exudative pleurisy. Diagnostic algorithm of peritoneal mesothelioma consists of analyzing the results of clinical examination with sequential application of ultrasound, multispiral computed tomography of the neck, thoracic, abdominal and small pelvis organs with intravenous bolus contrast (MSCTAG), positron emission tomography combined with computed tomography (PET/CT). Endovideoscopy with histologic and immunohistochemical examination of peritoneal biopsy specimens using mesothelial lineage antibodies and epithelial markers is the final and clarifying method of diagnostics of malignant peritoneal mesothelioma.
Romanov M.D., Davydkin V.I., Kireeva E.M. 2024. Difficulties in Diagnosing Peritoneal Mesothelioma (Rare Clinical Case). Challenges in Modern Medicine, 47(3): 388–398 (in Russian). DOI: 10.52575/2687-0940-2024-47-3-388-398
While nobody left any comments to this publication.
You can be first.
Barbolina T.D., Bagrova S.G. 2023. Sovremennyye podkhody k diagnostike i lecheniyu mezoteliomy [Modern Approaches to the Diagnosis and Treatment of Mesothelioma]. Obzor materialov konferentsii IMIG-2023. Chast′ 1: mezotelioma plevry. Zlokachestvennyye opukholi. 13(3s1): 140.
Volkov N.M., Barbolina T.D., Borisova T.N., Vladimirova L.Yu., Den′gina N.V., Levchenko E.V. 2023. Prakticheskiye rekomendatsii po lekarstvennomu lecheniyu mezoteliomy plevry, bryushiny i drugikh lokalizatsiy [Practical Recommendations for Drug Treatment of Mesothelioma of the Pleura, Peritoneum and Other Localizations]. Prakticheskiye rekomendatsii RUSSCO, chast′ 1. Zlokachestvennyye opukholi. 13(3s2): 72–88. doi: 10.18027/2224-5057-2023-13-3s2-1-72-88
Kaprin A.D., Starinskiy V.V., Shakhzadova A.O. 2022. Sostoyaniye onkologicheskoy pomoshchi naseleniyu Rossii v 2022 godu [The State of Cancer Care for the Population of Russia in 2022]. M., MNIOI im. P.A. Gertsena − filial FGBU «NMITS radiologii» Minzdrava Rossii: 239.
Koval′ T.I., Izyumskaya E.M., Marchenko E.G., Priymenko N.O., Kotelevskaya T.M., Bodnar V.A. 2021. Limfadenopatiya: algoritm diagnostiki i taktika vedeniya patsiyenta [Lymphadenopathy: Diagnostic Algorithm and Patient Management Tactics]. Klinicheskaya infektologiya i parazitologiya. 10(2): 187–199. doi: 10.34883/PI.2021.10.2.025.
Tarakanova O.V., Slavnova E.N., Tyusheva V.V., Bol′shakova D.A. 2023. Morfologicheskaya diagnostika mezoteliomy. Klinicheskiy sluchay [Morphological Diagnosis of Mesothelioma. Clinical case]. Novosti klinicheskoy tsitologii Rossii. 27(1): 15–19. doi: 10.24412/1562-4943-2023-1-0003
Alhamadh M.S., Alanazi R.B., Wadaan O.M., Alhabeeb A.Y., Alkaiyat M., Aljarbou O.Z., Sabatin F. 2023. Thrombocytosis as a Paraneoplastic Syndrome in Metastatic Malignant Peritoneal Mesothelioma of Biphasic Morphology Mimicking Ovarian Adenocarcinoma: A Case Report. Clin. Case Rep. Mar 2, 11(3): e6974. doi: 10.1002/ccr3.6974
Ali M., Elhatw A., Hegazy M., Albeyoumi H., Sakr N., Deyab A.M., Soliman A.Y., Said E., Samir Elbehwashy A., Nassar M., Alfishawy M. 2022. The Evaluation of Lymphadenopathy in a Resource-Limited Setting. Cureus. 14(10): e30623. doi: 10.7759/cureus.30623
Carlson B., Harmath C., Turaga K., Kindler H.L., Armato S.G. 3rd, Straus C. 2022. The Role of Imaging in Diagnosis and Management of Malignant Peritoneal Mesothelioma: A Systematic Review. Abdom. Radiol. (NY). 47(5): 1725–1740. doi: 10.1007/s00261-022-03464-x
Chun C.P., Song L.X., Zhang H.P., Guo D.D., Xu G.X., Li Y., Xin X., Cao J., Li F. 2023. Malignant Peritoneal Mesothelioma. Am. J. Med. Sci. 365(1): 99–103. doi: 10.1016/j.amjms.2022.07.008
Hiltbrunner S., Fleischmann Z., Sokol E., Zoche M., Felley-Bosco E. 2022. Genomic Landscape of Pleural and Peritoneal Mesothelioma Tumours. Br. J. Cancer. 127(11): 1997–2005
Huang X., Hong Y., Xie S.Y., Liao H.L., Huang H.M., Liu J.H., Long W.J. 2022. Malignant Peritoneal Mesothelioma with Massive Ascites as the First Symptom: A Case Report. World J. Clin. Cases. 10(28): 10317–10325. doi: 10.12998/wjcc.v10.i28.10317
Kuribayashi K., Kitajima K., Minami T., Ikeda M., Yamakado K., Kijima T. 2022. Malignant Peritoneal Mesothelioma Features Shown by FDG-PET/CT. Cancer Diagn. Progn. 2(6): 654–660. doi: 10.21873/cdp.10156
Kusamura S., Baratti D., De Simone M., Pasqual E.M., Ansaloni L., Marrelli D., Robella M., Accarpio F., Valle M., Scaringi S., Biacchi D., Palopoli C., Gazzanelli S., Guaglio M., Deraco M. 2023. Diagnostic and Therapeutic Pathway in Diffuse Malignant Peritoneal Mesothelioma. Cancers (Basel). 15(3): 662. doi: 10.3390/cancers15030662
Leci-Tahiri L., Zherka-Saracini H., Tahiri A., Koshi A. 2018. Bilateral Internal Jugular Vein Thrombosis Due to Malignant Tumor. Med. Case Reports. 12(1): 42. doi: 10.1186/s13256-017-1556-0
Liang X.L., Su Y.D., Li X.B., Fu Y.B., Ma R., Yang R., Wu H.L., Li Y. 2024. Risk Factors and Prognosis of Malignant Peritoneal Mesothelioma with Paraneoplastic Syndrome. World J. Surg. Oncol. 22(1): 29. doi: 10.1186/s12957-024-03312-w
Rao N., Wei S. 2022. Mesothelioma. Cytojournal. 19(10). doi: 10.25259/cmas_02_08_2021.
Sousa B., Silva J., Monteiro N., Romano M., Araújo E. 2023. Malignant Peritoneal Mesothelioma: A Case Report. Cureus. 15(8): e42902. doi: 10.7759/cureus.42902
Subahi E.A., Fadul A., Mohamed A., Alsayed A., Ali E.A., Sayed S., Mustafa S., Wazwaz B., Fadul M.H. 2024. Biphasic Peritoneal Mesothelioma Is a Rare Tumor and a Diagnostic Challenge: A Case Report. Cureus. 16(1): e51725. doi: 10.7759/cureus.51725
Sugarbaker P.H., Chang D., Jelinek J.S. 2021. Concerning CT Features Predict Outcome of Treatment in Patients with Malignant Peritoneal Mesothelioma. Eur. J. Surg. Oncol. 47(9): 2212–2219. doi: 10.1016/j.ejso.2021.04.012
Sun L., Li Ch., Gao Sh. 2023. Diffuse Malignant Peritoneal Mesothelioma: A Review. Front. Surg. 6(9): 1015884. doi: 10.3389/fsurg.2022.1015884
Tandon R.T., Jimenez-Cortez Y., Taub R., Borczuk A.C. 2018. Immunohistochemistry in Peritoneal Mesothelioma: A Single-Center Experience of 244 Cases. Arch. Pathol. Lab. Med. 142(2): 236–242. doi: 10.5858/arpa.2017-0092-OA
Ullah A., Waheed A., Khan J., Mishra A., Tareen B., Nama N., Karki N.R., Panezai M.S., Zarate L.V., White J., Cason F.D., Matolo N., Misra S., Karim N.A. 2022. Incidence, Survival Analysis and Future Perspective of Primary Peritoneal Mesothelioma (PPM): A Population-Based Study from SEER Database. Cancers (Basel). 14(4): 942. doi: 10.3390/cancers14040942
Verma R., Khera S. 2020. Cervical Lymphadenopathy: A Review. Int. J. Health Sci. Res. 10(10): 292–298.
Verma V., Sleightholm R.L., Rusthoven C.G., Koshy M., Sher D.J., Grover S., Simone C.B. (2018). Malignant Peritoneal Mesothelioma: National Practice Patterns, Outcomes, and Predictors of Survival. Annals of Surgical Oncology. 25(7): 2018–2026. doi: 10.1245/s10434-018-6499-1
Zannella S., Testi M.A., Cattoretti G., Pelosi G., Zucchini N. 2014. Peritoneal Malignant Mesothelioma Metastatic to Supraclavicular Lymph Nodes. Int. J. Surg. Pathol. 22(6): 552–554. doi: 10.1177/1066896913520037
Zeng X., Xu K., Zhang L., Huang X. 2022. Challenging Diagnostic Process for a Malignant Peritoneal Mesothelioma Patient with Ascites and Pleural Effusion: A Case Report and Review of the Literature. Front. Oncol. 15(12): 784064. doi: 10.3389/fonc.2022.784064
The work was carried out without external sources of funding.